Screening of CA19-9 negative pancreatic cancer specific biomarkers based on non targeted lipidomics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500110187

Enrollment

Unknown

Registered

2025-10-10

Start date

2026-01-01

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

CA 19-9 negative group:None

Healthy control group:None

CA 19-9 positive group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The pathological diagnosis is pancreatic ductal adenocarcinoma; 2. Not receiving anti-tumor or other treatments; 3. Data integrity; 4. Age over 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with severe dysfunction of organs such as the heart, lungs, and kidneys; 2. Merge with other tumors; 3. Individuals with mental or communication disorders.

Design outcomes

Primary

Measure	Time frame
carbohydrate antigen 19-9;	—

Countries

China

Contacts

Public ContactYang Jie

The First Hospital of Jiaxing

yangjie202305@163.com+86 188 6839 2068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026